Stephen Shrewsbury
Directeur/Bestuurslid bij BioXpertz LLC
Actieve functies van Stephen Shrewsbury
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
BioXpertz LLC | Directeur/Bestuurslid | - | - |
Loopbaan van Stephen Shrewsbury
Eerdere bekende functies van Stephen Shrewsbury
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Fortuna Fix, Inc.
Fortuna Fix, Inc. BiotechnologyHealth Technology Fortuna Fix, Inc. operates as a clinical-stage regenerative medicine firm. It develops a patented direct cell reprogramming technology platform (drNPC) and a proprietary bio-scaffolding technology (RMx), for the treatment of neurodegenerative diseases and neurotrauma. The company is headquartered in Laval, Canada. | Hoofd Techniek/Wetenschap/O&O | 01-06-2016 | 01-12-2016 |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Hoofd Techniek/Wetenschap/O&O | 03-04-2013 | 01-01-2016 |
SAREPTA THERAPEUTICS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-02-2009 | 20-06-2011 |
Algemeen Adviseur | 01-02-2009 | 20-06-2011 | |
ADAMAS PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-08-2008 | 01-08-2008 |
Algemeen Adviseur | 01-08-2008 | 01-08-2008 | |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Hoofd Techniek/Wetenschap/O&O | 01-03-2008 | 01-03-2008 |
Algemeen Adviseur | 01-03-2008 | 01-03-2008 | |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Corporate Officer/Principal | 01-02-2005 | 01-02-2005 |
IPI LEGACY LIQUIDATION CO | Hoofd Techniek/Wetenschap/O&O | 01-03-2017 | - |
GSK PLC | Directeur/Bestuurslid | - | - |
Corporate Officer/Principal | - | - |
Opleiding van Stephen Shrewsbury
The University of Liverpool | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Verenigd Koninkrijk | 3 |
Canada | 3 |
Operationeel
Chief Tech/Sci/R&D Officer | 6 |
General Counsel | 3 |
Corporate Officer/Principal | 2 |
Sectoraal
Health Technology | 9 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
SAREPTA THERAPEUTICS, INC. | Health Technology |
IPI LEGACY LIQUIDATION CO | Health Technology |
GSK PLC | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
MAP Pharmaceuticals LLC
MAP Pharmaceuticals LLC Medical SpecialtiesHealth Technology MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA. | Health Technology |
Adamas Pharmaceuticals LLC
Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It discovers and develops targeted therapeutics for inflammation and immuno-oncology. It also focuses on anti-inflammatory product candidates targeting SHIP1, which is a key regulator of an important cellular signaling pathway in immune cells, known as the PI3K pathway. The company was founded by Raymond J. Andersen, David J. Main, Low Fung Mui, Christopher John Ong, and Gerald Krystal on December 26, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
BioXpertz LLC | |
Fortuna Fix, Inc.
Fortuna Fix, Inc. BiotechnologyHealth Technology Fortuna Fix, Inc. operates as a clinical-stage regenerative medicine firm. It develops a patented direct cell reprogramming technology platform (drNPC) and a proprietary bio-scaffolding technology (RMx), for the treatment of neurodegenerative diseases and neurotrauma. The company is headquartered in Laval, Canada. | Health Technology |
- Beurs
- Insiders
- Stephen Shrewsbury
- Ervaring